Featured, “Authors Jim and Bob Rebitzer ask, "Why can't healthcare be better and cheaper?" (Live from The Players 2024 Championship),” Radio Advisory Podcast, May 14, 2024.
Author, “Why Not Better and Cheaper? Healthcare and Innovation,” Milken Institute Review, April 29, 2024.
Featured, “How to Overcome the Disruptive Forces That Can Impeded High-Value Innovation,” Healthcare Financial Management Association, April 28, 2024.
Author, “Shortages of Generic Drugs Can't be Blamed Solely on Group Purchasing Organizations,” STAT, April 25, 2024.
Featured, “Is Innovation Stuck in Healthcare? Two Brothers Get to The Bottom of It,” Healthcare is Hard Podcast, February 15, 2024.
Featured, “Bob Rebitzer, National Advisor at Manatt Health & Jim Rebitzer, Professor at Boston University's Questrom School of Business,” Becker’s Healthcare Podcast, February 8, 2024.
Co-author, “Patent buyouts could spur vital innovation in antibiotics, vaccines, and other medical fields,” STAT, November 14, 2023.
Featured, “Demand, supply, and the perils of unbalanced healthcare reform,” Niskanen Center, October 24, 2023.
Featured, “Why Not Better and Cheaper? Healthcare and Innovation,” WGN9, September 26, 2023.
Co-author, “AI Adoption in U.S. Health Care Won’t Be Easy,” Harvard Business Review, September 14, 2023.
Featured, “A lack of health care innovation is hurting patients and taxpayers,” The New York Times, September 6, 2023.
Co-author, “What the hospital-at-home movement tells us about igniting innovation in health care,” STAT, August 21, 2023.
Co-author, “Could a Subscription Model Spur Innovation in U.S. Health Care?,” Harvard Business Review, May 9, 2023.
Co-author, “Careful, Complicated Planning Will Bring Fans Back,” Sports Business Journal, June 8, 2020.
Co-author, “Opioid Safety Toolkit,” California Health Care Foundation, February 2019.
Co-author, “America’s Opioid Crisis,” Bloomberg BNA’s Pharmaceutical Law & Industry Report, March 30, 2018.